Thinle Chodon to Multiple Myeloma
This is a "connection" page, showing publications Thinle Chodon has written about Multiple Myeloma.
Connection Strength
0.165
-
Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401. Clin Cancer Res. 2023 12 01; 29(23):4784-4796.
Score: 0.165